XenoPort xenoport.com


Public lists: Pharma Startups (4740)

XenoPort is a biopharmaceutical company that is focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.

XenoPort is a biopharmaceutical company that is focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.

Company (Acquired)

Phone: 408-616-7200

Fax:

3410 Central Expressway

Santa Clara, 95051
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
XenoPort $238.1M May 23, 2016
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related XenoPort Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 24 investors

Board Members

Competitors

Company Status Description Investors

Allos Therapeutics

Westminster, Colorado, United States
AcquiredAllos Therapeutics is a biopharmaceutical company focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company's lead product candidate, pralatrexate (PDX) is a novel antifolate currently under evaluation in a pivotal Phase 2 (PROPEL) trial in patients with relapsed or refractory peripheral T-cell lymphoma. The PROPEL trial is being conducted under an agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or ...Show allLogin to see details

Epix Pharmaceuticals

Lexington, Massachusetts, United States
Dead / InactiveEPIX Pharmaceuticals, formed from the merger of Predix Pharmaceuticals and Epix Pharmaceuticals, is a biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products through the use of technology to better diagnose, treat and manage patients.Login to see details
See all 15 competitors